Education
About Us
Working with TipRanks
Follow Us
Phillip Febbo Insider Profile
4 Followers
Phillip Febbo, CMO at Genomic Health, holds 92.44K shares in Veracyte (Ticker: VCYT), holds 14.79K shares in Illumina (Ticker: ILMN), holds 0.00 shares in Varian Medical Systems (Ticker: VAR).
Phillip Febbo Genomic Health (GHDX)CMO
Genomic Health (GHDX)
CMO
Not Ranked
Phillip Febbo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Phillip Febbo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Phillip Febbo
Phillip Febbo's Trading History
Genomic Health
Feb 22, 2018
―
Uninformative Sell
162.26K
$1.36M
Illumina
Mar 03, 2023
SVP Chief Medical Officer
Uninformative Buy
―
$1.41M
Varian Medical Systems
Apr 16, 2021
―
Uninformative Sell
―
$0.00
Veracyte
Oct 07, 2025
Chief Scientific & Med Officer
Uninformative Sell
300.65K
$3.31M
List of latest transactions for each holding click on a transaction to see Phillip Febbo's performance on stock
You May Also Like
Phillip Febbo insider profile FAQ
What is the percentage of profitable transactions made by Phillip Febbo?
The percentage of profitable transactions made by Phillip Febbo is ―.
What is the average return per transaction made by Phillip Febbo?
The average return per transaction made by Phillip Febbo is ―.
What stocks does Phillip Febbo hold?
Phillip Febbo holds: GHDX, ILMN, VAR, VCYT stocks.
What was Phillip Febbo’s latest transaction?
Phillip Febbo latest transaction was an Uninformative Sell of $300.65K.
What was Phillip Febbo's most profitable transaction?
Phillip Febbo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Phillip Febbo's role in Genomic Health?
Phillip Febbo's role in Genomic Health is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.